Deuterated Compounds

Applications 2,3-Dichlorobenzamidyl Guanidine-13C2 (cas# 1185047-08-8) is a compound useful in organic synthesis.

Applications Chemical building block used in the synthesis of more complex structures.

Applications 4-[4-(Diphenylmethoxy-d5)-1-piperidinyl]-1-[4-[(2-hydroxy-1,1-dimethyl)ethyl]phenyl]butyne (cas# 1189696-09-0) is a compound useful in organic synthesis.

Applications Trimethylphenylammonium-d9 Iodide (cas# 88278-22-2) is a compound useful in organic synthesis.
References Dorweiler, J., et al.: Biochem., 42, 14653 (2003),

Applications Hydrazine derivative.

Applications Ethyl Cyanoacetate-13C2 (cas# 93664-96-1) is a compound useful in organic synthesis.
Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package

Applications 4-[2-(1-Piperidinyl)ethoxy-d4]benzoic Acid, Hydrochloride Salt (cas# 1246815-60-0) is a compound useful in organic synthesis.

Applications 4-Chloro Resorcinol-13C6 (cas# 953390-32-4) is a compound useful in organic synthesis.

Applications 4-​(Dimethylamino)​benzoic-​2,​3,​5,​6-​d4 Acid is an intermediate in the synthesis of DMABA-d4 NHS Ester (D678402), which is a labelled DMABA NHS ester (D678400). DMABA NHS ester is a reagent that reacts with the primary amine group of PE lipids. DMABA NHS ester has been used in combination with DMABA NHS ester-d4, -d6, and -d10 to study relative changes in PE lipid abundance before and after radical oxidation.
References Wester, H., et al.: Nucl. Med. Bio., 23, 365 (1996), Frees, D., et al.: Mol. Microbiol., 48, 1565 (2003), Michel, A., et al.: J. Bacteriol., 188, 5783 (2006), Voelker, T., et al.: Bioorg. Med. Chem., 17, 2047 (2009),

Applications Ethanolamine-d7 (CAS# 1219802-89-7) is a useful isotopically labeled research compound.

Applications Phenoxy-d5-acetic Acid Ethyl Ester (cas# 1189442-18-9) is a compound useful in organic synthesis.

Applications A labelled biodegradation product of Malathion (M111000).
Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package
References Kim, Y. et al.: Chemosphere, 60, 1349 (2005); Yoshii, K. et al.: J. Health Sci., 54, 535 (2008); Hayasaka, M. et al.: Jap. J. Forensic Toxicol., 12, 15 (1994);

Applications Labelled Sodium Cyanoborohydride is a commonly used as a reagent in the reductive amination of aldehydes and ketones and in the reductive alkylation of amines.
Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package
References Hsu, J. et al.: J. Am. Soc. Mass Spec., 17, 194 (2006); Ducrocq, C. et al.: J. Label. Comp. Radiopharm., 22, 61 (1985);

Applications Labelled analogue of Potassium Cyanide, a reagent widely used in organic synthesis for the preparation of nitriles and carboxylic acids, particularly in the von Richter reaction.
Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package
References Kollenz, G. et al.: Org. Prep. Proc. Int., 12, 244 (1980); Subramanian, L. R.: Sci. Synth., 19, 173 (2004);

Applications N-Boc-N-methylpiperazine-d8 (cas# 1189436-83-6) is a compound useful in organic synthesis.

Applications Alfuzosin labelled intermediate as potential α1-adrenoceptor antagonist.
References Manoury, P. M. , et al.: J. Med. Chem., 29, 19 (1986),

Applications 2-[(5-Benzyloxypyridin-2-yl)methylamino]ethanol-d4 (cas# 1794786-87-0) is a compound useful in organic synthesis.

Applications Intermediate in the synthesis of labelled heteroarotinoids.
References Dawson, M.I. et al.; J. Med. Chem. 27, 1516 (1984); Waugh, K.M. et al.; J. Med. Chem. 28, 116 (1985); Spruce, L.W. et al.; J. Med. Chem. 30, 1474 (1987)

Applications Labelled analogue of N-Methyl-N,N-bis(2-pyridylethyl)amine, a reagent in the preparation of copper pyridylmethylethylenediamine dicyanamido polymeric complexes.
References Mautner, F.A. et al.: Inorg. Chim. Acta, 362, 4073 (2009);

Applications (S)-1-Boc-3-hydroxypiperidine-d4 is an intermediate in synthesizing Ibrutinib-d4 (I124971), a labelled analogue of Ibrutinib (I124970). Ibrutinib is a highly selective Bruton’s tyrosine kinase (Btk) irreversible inhibitor.
Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package
References MacGlashan, D., et. al.: Int. Immunol., 11, 475 (2011)

Applications An intermediate for the synthesis of Tamoxifen.
References Ruenitz, P.C., et al.: Biochem. Pharmacol., 34, 2807 (1985), Gilbert, J., et al.: J. Med. Chem., 40, 1104 (1997), Lashley, M.R., et al.: Bioorg. Med. Chem., 10, 4075 (2002),

Applications 4-(4-Chlorophenyl)-1-imidazol-1-yl-(butan-d5)-2-ol (cas# 1185063-39-1) is a compound useful in organic synthesis.

Applications rac-N-Benzyl-3-(4-methoxyphenyl)-2-propylamine-d6 (cas# 1174538-53-4) is a compound useful in organic synthesis.
References Jozwiak, K., et al.: J. Med. Chem., 50, 2903 (2007),

Applications Rosiglitazone (Rosiglitazone (R693500) Rosiglitazone (R693500) ) derivative.Thiazolidinedione derivative, with antidiabetic properties.

Applications Reagent used in the preparation of labelled cyclopropane derivatives.
References Antipenko, L., et al.: Chem. Pharm. Bull., 57, 580 (2009), Kumar, A., et al.: Bioorg. Med. Chem., 17, 5285 (2009),

Applications Reactant used in the preparation of labelled Camptothecin derivatives.

Applications N-[2-(S)-Methyl-d3-butyryl]-4-(S)-phenylmethyl-2-oxazolidinone (cas# 1073232-99-1) is a compound useful in organic synthesis.

Applications 1,4-Di(hydroxymethyl)benzene-d4 (cas# 1158734-28-1) is a compound useful in organic synthesis.

Applications An intermediate in the synthesis of the Daspone metabolite.

Applications 1-Bromotridecane-1,1,2,2-d4 (CAS# 284474-45-9) is a useful isotopically labeled research compound.

Applications Terconazole-d4 is the isotope labelled analog of Terconazole (T110600); a compound used for topical treatment of mycotic vaginitis. Terconazole may also be used in vitro as a potent antifungal agent to prevent the morphogenetic transformation of yeast into the (pseudo-)mycelium form of Candida albicans.
References Cauwenbergh, G., Vanden Bossch H.: J. Reprod. Med., 34, 588 (1989); Del Palacio-Hernanz, A., et. al.: Chemioterapia, 3, 192 (1984); Van Cutsem, J., et. al.: Chemotherapy, 29, 322 (1983)

Applications 3,4-Difluoroaniline-2,6-d2 (CAS# 1061566-62-8) can be used in its derivative form as an antiviral agent for Hepatitis B.
References Qiu, Y.L., et.al., U.S. Pat. Appl. Publ., 187,(2019);

Applications L-Lysine-DL-amphetamine-d6 2HCl (propane-1,1,2,3,3,3-d6) (CAS# 1276056-89-3) is a useful isotopically labeled research compound.

Applications L-4-Hydroxyphenyl-3,5-d2-alanine (CAS# 30811-19-9) is a useful isotopically labeled research compound.

Applications 13-cis-Retinoic Acid-d5, is the labeled analogue of 13-cis-Retinoic Acid (R250000) used as a treatment for severe acne. Presently being studied in conjuction with the treatment of photoaged skin.
References Lerche, C., et al.: Exp. Dermatol., 17, 972 (2008), Sato, T., et al.: J. Med. Chem., 51, 7705 (2008), Gan, J., et al.: Chem. Res. Toxicol., 22, 690 (2009), Macejova, D., et al.: Toxicol. Lett., 184, 114 (2009), Chen, P., et al.: Toxicol. App. Pharmacol., 234, 143 (2009),

Applications n-Hexyl 4-Hydroxybenzoate-2,3,5,6-d4 is the isotope labelled analog of n-Hexyl 4-Hydroxybenzoate; a phenolic acid alkyl ester/paraben that shows antimicrobial activity and antioxidant properties.
References Merkl, R., et al.: Czech J. Food Sci., 28, 275 (2010)

Applications 1,2-Dimethoxybenzene-d10 (CAS# 362049-43-2) is a useful isotopically labeled research compound.

Applications DL-Homocysteine Thiolactone-3,3,4,4-d4 HCl (CAS# 1219805-31-8) is a useful isotopically labeled research compound.

Applications L-Proline-d3-N-Fmoc was used to prepare potent bombesin-like peptides for GRP-receptor targeting of tumors. It was also used to synthesize tetrapeptide aldehyde inhibitors of dengue virus NS3 protease.
References Nock, B., et al.: J. Med. Chem., 48, 100 (2005); Yin, Z., et al.: Bioorg. Med. Chem. Lett., 16, 40 (2006)

Applications A labelled Voriconazole (V760000) impurity.
References Rieke, R., et al.: Science, 246, 1260 (1989), Dickinson, R., et al.: Bioorg. Med. Chem. Lett., 6, 2031 (1996),